Roznik, Katerina http://orcid.org/0000-0002-5403-8747
Xue, Jiashu
Stavrakis, Georgia
Johnston, T. Scott http://orcid.org/0000-0002-8662-541X
Kalluri, Divya
Ohsie, Rivka
Qin, Caroline X.
McAteer, John
Segev, Dorry L.
Mogul, Douglas
Werbel, William A.
Karaba, Andrew H. http://orcid.org/0000-0003-2785-317X
Thompson, Elizabeth A. http://orcid.org/0000-0001-8464-9904
Cox, Andrea L. http://orcid.org/0000-0002-9331-2462
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (U54CA260492)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (U01AI138897, K23AI157893, K08AI156021)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Article History
Received: 6 August 2023
Accepted: 19 March 2024
First Online: 5 April 2024
Competing interests
: W.A.W. received advisory board fees from Novavax and consulting fees from AstraZeneca and GlobalData. W.A.W. is a consultant for the CDC/IDSA COVID-19 Real-Time Learning Network. The remaining authors declare no competing interests.